Co-Authors
This is a "connection" page, showing publications co-authored by Payam Tabarsi and Ehsan Sharifipour.
Connection Strength
0.283
-
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102.
Score: 0.227
-
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfus Apher Sci. 2020 Oct; 59(5):102875.
Score: 0.056